We just capped insulin copays at $35/mo. Media, feel free to convey the significance of that at any time.

It's hard to fathom a policy so directly impacting millions of Americans. Instead, media has focused elsewhere producing massive amounts of redundant content. It's a major failing.

We just capped insulin copays at $35 per month. It's hard to fathom a policy so directly impacting millions of Americans. The extreme, redundant media focus elsewhere is worrisome because it suggests a prioritization of ad revenue over informing the public.

The story of lowering the price of insulin began long ago but the last administration also made promises about lowering the cost of insulin. The interesting detail therein is that the HHS secretary appointed by Trump was a pharmaceutical lobbyist who is well-known for overseeing a 325% increase in the price of insulin.

When Trump appointed him, Azar was the President of a major pharmaceutical company. Republicans nearly unanimously confirmed Azar. That alone was reason to question the sincerity of a promise to lower the cost of a drug discovered a century ago. Between 2017 and 2018, insulin copays for seniors rose.

At the same time, that tweet was posted, we were enduring the consequences of a botched pandemic response that was at least partially linked to the HHS secretary of insulin-price-fame who was unqualified for his position. This was a rare moment where politicians did their job and they did it well.

While we often see a lot of carefully worded political theater related to healthcare and manufactured culture wars, this has been a meaningful change that will improve the quality and length of life for millions.

Getting insulin to those who will die without has been a century-long battle. Our greatest success thus far deserves more than a footnote, even if it isn't going to nab as many clicks.

Novel Science
Everything You Should Know About ACA and the History of Health Insurance in the US
The following was published by Being Well in November of 2020. The US Supreme Court began work on the Affordable Care Act (ACA) case, formally known as California V. Texas, on November 10, 2020. The Trump administration and the Department of Justice (DOJ) argue that the ACA …
Read more


Thanks for reading Novel Science! Subscribe for free to receive new posts and support our work.